AwardedPOLGoods
Dostawa produktów leczniczych - Mirvetuximabum Soravtansinum
- Published
- Published 4 March 2026
- Deadline
- Closed 3 April 2026
Overview
The Franciszek Łukaszczyk Oncology Centre in Bydgoszcz procured the pharmaceutical product Mirvetuximabum Soravtansinum. The contract was awarded to Abbvie Sp. z o.o. on 27 April 2026 for a value of 38,499,978 PLN.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- SME suitable
- Yes
- Published
- 4 March 2026
- Deadline
- Closed
Antineoplastic agents
Award outcome
- Awarded value
- PLN 38,499,978
- Award date
- 27 April 2026
- Contract period
- — → 16 April 2028
- Abbvie Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
29 April 2026
Contract Notice
4 March 2026
Contracting authority
Centrum Onkologii im. Franciszka Łukaszczyka w Bydgoszczy
Procuring entityBydgoszcz, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.